glp-1 obesity drug news updates Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine New research is challenging long-held

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide and tirzepatide, have emerged as transformative agents for type 2 diabetes and obesity through their potent effects on weight reduction, insulin sensitivity, and cardiovascular outcomes

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.

Explore GLP-1 medications like Ozempic and Wegovy

Correspondent Tracy Smith talks with experts who say the drugs might prove useful in treating other diseases associated with obesity (including cancer)

Struggling with constipation on GLP-1 medications like Ozempic or Wegovy